Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"October 27, 2026 2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . “
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Medicaid expansion did not markedly lower IBD mortality, despite a smaller increase in expansion states. Improved specialist access and biologic drug availability may be needed to reduce IBD mortality. NASHVILLE, Tenn. \u2014 Medicaid expansion did not appear to reduce inflammatory bowel disease-specific mortality over a 26-year period, according to a presenter at ACG Annual Scientific Meeting. However, researchers noted these findings should not minimize the benefits Medicaid coverage provides patients with IBD.
\u201cWhat stood out to me was the importance of interpreting that result within the outcome we measured,\u201d Daniyal Raza, MD, assistant professor of medicine at LSU Health Shreveport, told Healio. \u201cMortality is a consequential endpoint, but it captures only one part of living with IBD. Our study does not tell us whether patients experienced better symptom control, fewer hospitalizations, more consistent treatment or improved quality of life. \u201cA null mortality finding is not a comprehensive verdict on the value of insurance coverage,\u201d he added. Raza and colleagues conducted a retrospective, state-level difference-in-differences (DiD) analysis to determine whether Medicaid expansion was linked to change in IBD-related mortality over time. They used CDC death certificate data attributed to Crohn\u2019s disease or ulcerative colitis and included all ages in the analysis. \u201cThe question grew out of a practical concern: Patients with IBD need sustained access to care, but obtaining insurance does not necessarily end the difficulties they face getting treatment,\u201d Raza said. \u201cPrior authorization denials, appeals and delays in starting medications can remain obstacles.\u201d Analysis included 21 states, which were grouped by those that expanded Medicaid coverage by January 2016 (n = 14) and those that had not through 2024 (n = 7). The researchers compared mean age-adjusted IBD mortality per 100,000 deaths between the two groups prior to expansion (1999-2013) and after expansion (2017-2024), excluding years 2014 to 2016 to allow for stabilization in Medicaid enrollment and use. Results showed states that expanded Medicaid coverage had a smaller increase in IBD mortality compared with states that did not expand coverage (relative change, +1% vs. +4.9%), but the difference was not statistically significant (DiD = 0.005; 95% CI, \u20130.022 to 0.031). A secondary analysis of individuals aged 15 to 64 years, using data pooled from 2007 to 2013 and from 2018 to 2024, also showed a smaller increase in IBD mortality in expansion states (+1.2% vs. +17.5%), which did not reach statistical significance. The researchers acknowledged study limitations, including use of state-level data rather than patient-level data, and differences in pre-expansion trends. \u201cOur study did not demonstrate a mortality difference associated with Medicaid expansion, but it should not be interpreted as evidence that coverage is unimportant,\u201d Raza told Healio. \u201cFor GI practices, the practical focus remains identifying where care gets interrupted: an authorization awaiting approval, an unaffordable prescription or difficulty arranging follow-up. \u201cThe question I would bring back to clinic is: Once a patient has coverage, what is still preventing them from receiving effective care?\u201d he added. For more information: Daniyal Raza, MD, can be reached at daniyal.raza@lsuhs.edu. Published by: Sources\/Disclosures Source: Raza D, et al. Medicaid expansion and IBD mortality: A state-level difference-in-differences analysis, 1999-2024. Presented at: ACG Annual Scientific Meeting; Oct. 12-14, 2026; Nashville, Tenn. (hybrid meeting).
Disclosures:
Raza reports no relevant financial disclosures. Please see the study for all other authors\u2019 relevant financial disclosures.
Ask a clinical question and tap into Healio AI’s knowledge base.
PubMed, enrolling\/recruiting trials, guidelines
Clinical Guidance, Healio CME, FDA news
Healio’s exclusive daily news coverage of clinical data
Learn more
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . “
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Source link<\/p>\n","protected":false},"author":1,"featured_media":4162,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4161","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/4161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4161"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/4161\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/4162"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Healio](\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hgld\/healio_gastro.svg?la=en&h=40&w=152&hash=2C654A538F2E250F5183D42A89FE0EC0\")
\n <\/div>\n<\/p><\/div>\n<\/p><\/div>\n